Kishor A. Dandekar

Toxicokinetics of 2′,3′-Didehydro-3′-Deoxythymidine, Stavudine (D4T)

Sanjeev Kaul, Kishor A. Dandekar, Beth E. Schilling et al. · Drug Metabolism and Disposition · 1999 · 34 citations

High-performance liquid chromatographic determination of 2′,3′-didehydro-3′-deoxythymidine, a new anti-human immunodeficiency virus agent, in human plasma and urine

John Janiszewski, Daniel Mulvana, Sanjeev Kaul et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1992 · 29 citations

Medicinal Chemistry, Biochemistry, Medicine +15

The effect of site of application on the transcutaneous absorption of 17-β estradiol from a transdermal delivery system (Climara)

William Taggart, Kishor A. Dandekar, Herman Ellman et al. · Menopause The Journal of The North American Menopause Society · 2000 · 27 citations

Analytical Method for the Quantification of 2′,3′-Didehydro-3′-Deoxythymidine, a New Anti-Human Immunodeficiency Virus (HIV) Agent, by High-Performance Liquid Chromatography (HPLC) and Ultraviolet (UV) Detection in Rat and Monkey Plasma

Sanjeev Kaul, Kishor A. Dandekar, Kenneth A. Pittman · Pharmaceutical Research · 1989 · 20 citations

Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.

Rashmi H. Barbhaiya, Kishor A. Dandekar, Douglas S. Greene · Drug Metabolism and Disposition · 1996 · 16 citations